UBS Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103M Sell
2,393,513
-1,328,821
-36% -$57.1M 0.02% 1029
2025
Q4
$163M Buy
3,722,334
+1,067,265
+40% +$44.2M 0.03% 680
2025
Q3
$110M Buy
2,655,069
+1,328,087
+100% +$53.4M 0.02% 965
2025
Q2
$58.5M Sell
1,326,982
-711,050
-35% -$28.4M 0.01% 1371
2025
Q1
$75.2M Buy
2,038,032
+1,060,112
+108% +$37.8M 0.02% 1121
2024
Q4
$32.6M Buy
977,920
+401,211
+70% +$13M 0.01% 1846
2024
Q3
$15M Sell
576,709
-58,183
-9% -$1.45M ﹤0.01% 2054
2024
Q2
$14.3M Buy
634,892
+130,066
+26% +$2.89M ﹤0.01% 1948
2024
Q1
$12M Buy
504,826
+60,289
+14% +$1.34M ﹤0.01% 2120
2023
Q4
$10.7M Sell
444,537
-90,046
-17% -$1.96M ﹤0.01% 2037
2023
Q3
$11.7M Buy
534,583
+163,214
+44% +$3.41M 0.01% 1871
2023
Q2
$7.1M Sell
371,369
-31,358
-8% -$604K ﹤0.01% 2252
2023
Q1
$7.82M Sell
402,727
-223,730
-36% -$3.9M ﹤0.01% 2093
2022
Q4
$10M Buy
626,457
+457,171
+270% +$7.46M ﹤0.01% 1926
2022
Q3
$2.65M Sell
169,286
-468,535
-73% -$9.05M ﹤0.01% 2908
2022
Q2
$13.3M Buy
637,821
+395,724
+163% +$8.15M 0.01% 1617
2022
Q1
$5.49M Sell
242,097
-383,276
-61% -$7.49M ﹤0.01% 2446
2021
Q4
$11.4M Buy
625,373
+151,865
+32% +$2.91M ﹤0.01% 2025
2021
Q3
$10M Buy
473,508
+84,727
+22% +$1.57M ﹤0.01% 2029
2021
Q2
$7.08M Buy
388,781
+60,625
+18% +$1.41M ﹤0.01% 2338
2021
Q1
$7.41M Buy
328,156
+158,513
+93% +$3.58M ﹤0.01% 2222
2020
Q4
$3.4M Buy
169,643
+13,084
+8% +$274K ﹤0.01% 2864
2020
Q3
$3.83M Buy
156,559
+84,517
+117% +$1.97M ﹤0.01% 2446
2020
Q2
$1.71M Sell
72,042
-28,575
-28% -$662K ﹤0.01% 3023
2020
Q1
$1.73M Sell
100,617
-242,444
-71% -$4.43M ﹤0.01% 2887
2019
Q4
$6.04M Sell
343,061
-271,390
-44% -$4.6M ﹤0.01% 2434
2019
Q3
$10.9M Buy
614,451
+362,021
+143% +$7.33M 0.01% 1703
2019
Q2
$5.39M Buy
252,430
+17,605
+7% +$369K ﹤0.01% 2263
2019
Q1
$5.59M Sell
234,825
-270,920
-54% -$6.18M ﹤0.01% 2117
2018
Q4
$9.95M Buy
505,745
+274,190
+118% +$4.89M 0.01% 1573
2018
Q3
$4.1M Buy
231,555
+134,647
+139% +$2.63M ﹤0.01% 2533
2018
Q2
$2.08M Sell
96,908
-296,208
-75% -$6.13M ﹤0.01% 3126
2018
Q1
$8.71M Buy
393,116
+243,361
+163% +$6.73M ﹤0.01% 1823
2017
Q4
$4.55M Sell
149,755
-60,853
-29% -$1.62M ﹤0.01% 2443
2017
Q3
$5.1M Buy
210,608
+124,659
+145% +$3.32M ﹤0.01% 2182
2017
Q2
$2.12M Buy
85,949
+53,390
+164% +$1.13M ﹤0.01% 2960
2017
Q1
$706K Sell
32,559
-53,428
-62% -$1.09M ﹤0.01% 3795
2016
Q4
$1.28M Buy
85,987
+18,365
+27% +$265K ﹤0.01% 3339
2016
Q3
$865K Sell
67,622
-56,839
-46% -$615K ﹤0.01% 3523
2016
Q2
$972K Buy
124,461
+41,466
+50% +$239K ﹤0.01% 3403
2016
Q1
$332K Sell
82,995
-511,711
-86% -$2.17M ﹤0.01% 4104
2015
Q4
$3.35M Buy
594,706
+494,954
+496% +$2.77M ﹤0.01% 2309
2015
Q3
$560K Buy
99,752
+13,720
+16% +$74.7K ﹤0.01% 3807
2015
Q2
$323K Buy
86,032
+11,769
+16% +$38.3K ﹤0.01% 4456
2015
Q1
$191K Sell
74,263
-19,668
-21% -$45.6K ﹤0.01% 4931
2014
Q4
$135K Buy
+93,931
New +$146K ﹤0.01% 5400

Other funds holding EXEL